aTyr Pharma Inc (NASDAQ:LIFE)
| 2.26 Delayed Data As of May 31 |  -0.02 / -0.88%Today’s Change | 1.56 Today|||52-Week Range 4.28 | +3.20% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $130.3M |
Company Description
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Contact Information
aTyr Pharma, Inc. 10240 Sorrento Valley Road San Diego California 92121 |
Employees
Shareholders
| Mutual fund holders | 34.84% |
| Other institutional | 28.09% |
| Individual stakeholders | 2.34% |
Top Executives
| Sanjay S. Shukla | President, Chief Executive Officer & Director |
| Jill M. Broadfoot | Chief Financial Officer |
| Leslie Nangle | Vice President-Research |
| Andrew B. Cubitt | Vice President-External Scientific Alliances |
| Peter Villiger | Vice President-Corporate Development |
